Research Topics
| P V GrootendorstSummaryAffiliation: McMaster University Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugsP V Grootendorst
Department of Clinical Epidemiology and Biostatistics, McMaster University, and Centre for Evaluation of Medicines, St Joseph s Hospital, Hamilton, Ont
CMAJ 165:1011-9. 2001..We estimated the effect of reference-based pricing of nitrate drugs used for long-term prophylaxis on prescribing of and expenditures on nitrates and other anti-anginal drugs dispensed to senior citizens in British Columbia...
Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessmentPaul Grootendorst
McMaster University and Centre for Evaluation of Medicines, Hamilton, Ontario, Canada
Can J Clin Pharmacol 9:79-99. 2002..Each province has, however, provided coverage to senior citizens and social assistance recipients; some provinces have introduced drug coverage for the general public...
Health care policy evaluation using longitudinal insurance claims data: an application of the panel Tobit estimatorP V Grootendorst
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
Health Econ 6:365-82. 1997..Little evidence of transitory effects to insurance coverage was found. Finally, the extension of insurance has made only a minor contribution to growth in seniors' drug use, relative to secular growth in drug use over time...
Effect of copayments on drug use in the presence of annual payment limitsGeorge Kephart
Department of Community Health and Epidemiology, Dalhousie University, Halifax, NS, Canada
Am J Manag Care 13:328-34. 2007....
A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British ColumbiaPaul Grootendorst
Faculty of Pharmacy, University of Toronto, Toronto, Ont, Canada
Health Econ 15:735-42. 2006..We find that controlling for such factors reduces estimates of drug plan savings attributable to RP of the Calcium Channel Blockers by about half...
Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysisDeborah Marshall
Innovus Research Inc, 1016 A Sutton Drive, Burlington, Ontario L7L 6B8, Canada
J Health Serv Res Policy 11:13-20. 2006..Our objective was to determine the impact of this policy on the volume and cost of antibiotic prescribing...
Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, CanadaPaul Contoyannis
Centre for Health Economics and Policy Analysis, McMaster University, Canada
Health Econ 14:909-23. 2005..Our preferred specification leads to expenditure elasticities that are in the low range of previous estimates (between -0.12 and -0.16). Naïve OLS estimates are between 1 and 4 times these magnitudes...
Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residentsSebastian Schneeweiss
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
Med Care 42:653-60. 2004..Critics argued that drug plan savings are offset by administrative costs and increased spending on other health services...
The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from CanadaSule Alan
Department of Economics, York University, Toronto, Canada
J Health Econ 21:805-26. 2002..Such evidence may have relevance for predicting the redistributive effects of a potential national prescription drug plan for seniors in the US...
The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from CanadaDeborah A Marshall
Centre for Evaluation of Medicines, 105 Main Street East, Level P1, Hamilton, ON L8N 1G6, Canada
Health Policy 84:1-13. 2007..Ontario required physicians to submit the clinical indications for their use on the prescription. British Columbia required physicians to seek and receive prior authorisation from the drug plan...
Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidenceJoel Lexchin
School of Health Policy and Management at York University, Toronto, Canada
Int J Health Serv 34:101-22. 2004..Cost sharing also leads to patients foregoing essential medications and to a decline in health care status...
Coding accuracy of administrative drug claims in the Ontario Drug Benefit databaseAdrian R Levy
Centre for Health Evaluation and Outcome Sciences, St Paul s Hospital, Vancouver, Canada
Can J Clin Pharmacol 10:67-71. 2003....
Validity of self-reported prescription drug insurance coveragePaul Grootendorst
Faculty of Pharmacy, University of Toronto, Toronto, Ontario, M5S 2S2
Health Rep 14:35-46. 2003..This article assesses the validity of prescription drug insurance coverage as self-reported in the 1996/97 National Population Health Survey (NPHS)...
Dental insurance, income and the use of dental care in CanadaTaimur Bhatti
Ontario Ministry of Health and Long Term Care, Toronto, Ontario, Canada
J Can Dent Assoc 73:57. 2007....
